Back

C Suite Market Update - July 2014

July 2014

This month we saw some significant increases over the same month in 2013 and continued momentum over last month.  The only area that saw a decline in turnover activity was CFO’s.  Three key areas saw significant increased turnover activity: CEO changes were up 18% over the same month last year; overall C-level changes increased 11%; and Board changes rose by 21% over last year. CFO changes were down slightly – by 4%. Month over month changes were as follows: +38% for CEO’s; overall C-level changes +30%; Board changes +48%; and CFO changes -13%.
 
Executive turnover activities break down as follows:

  • CEO changes, +18%.   A total of  225 changes with the largest number of changes occurring in drugs/biotech, business services and banking. Last month's changes occurred primarily in drugs, automotive and energy.  
  • CFO changes, -4%   A total of 158 changes with the largest number of changes occurring in drugs/biotech, banking, business services and energy. Last month's changes occurred primarily in drugs, automotive and energy.
  • Board of Directors,  +48%   A total of 556 changes with the largest number of changes occurring in drugs/biotech, banking and energy. Last month saw changes primarily in the same sectors: drugs/biotech, banking and energy.
  • Overall C suite, +30%.  A total of 1570 changes with the largest number of changes occurring in drugs/biotech, business services and banking. Last month's changes occurred in drugs/biotech, business services and energy.

Overall indicators are that the North American economy continues to rebound at a healthy rate and should continue to do so through the fall.